The International Paediatric Onco-Critical Care Symposium (IPOCCS) brings together international experts to discuss current challenges and advances in the field of paediatric onco-critical care. The goal of this symposium is to advance the care of critically ill paediatric haematology/oncology patients through improvements in patient care, multidisciplinary collaboration, as well as clinical and translational research.
IPOCCS is organized in collaboration by St. Jude Children’s Research Hospital, Great Ormond Street Hospital for Children, and the Princess Máxima Center for Pediatric Oncology.
Event hosts
Melissa Hines, MD
Associate Member
Division of Critical Care Medicine
Caitlin Hurley, MD
Associate Member
Division of Critical Care Medicine
Event Contact:
Shannon Smith
poccs@stjude.org
-
Fees
Registration Type In-Person Virtual Physicians, Advanced Practice Providers, Nurses, and Respiratory Therapists
- $300 until January 20, 2026
- $500 after January 20
- $250 until January 20
- $400 after January 20
Medical Trainees (Students, Residents, Fellows)
- $200 until January 20
- 250 after January 20
- $150 until January 20
- $200 after January 20
Low to Middle Income Countries (LMIC) attendees
- $25
- $25
St. Jude Children's Research Hospital and Le Bonheur Children's Hospital employees and trainees
- $100
- $100
Onco-Critical Care Fundamentals Day (Tuesday, April 14)*
- $50 general
- $15 LMIC
- $50 general
- $15 LMIC
Onco-Critical Care Fundamentals Day: Tuesday, April 14
This educational pre-day will describe current literature and management of oncologic specific emergencies in critical care in all potential settings (including middle- and lower-income settings) and outline key differences between critically ill oncologic patients and critically ill general pediatric patients. Sessions will be lectures followed by expert panel discussion. Please bring all your questions!
This can be added to your registration by selecting “Onco-Critical Care Fundamentals Day” prior to checkout.
-
Hotel
The Peabody Memphis is the official hotel for the International Paediatric Onco-Critical Care Symposium. A special room block has been reserved at a rate of $240 per night.
Transportation
Transportation will be provided from The Peabody to St. Jude campus and back. Attendees staying at other hotels should plan to meet at The Peabody to take the shuttle. Please note that personal vehicles are not permitted on campus.
-
Tentative Agenda
Lessons from a Clinical Researcher Looking at Genetic Differences in Pediatric Critical Illness
- Heidi Flori, MD, FAAP
University of Michigan - Mary K. Dahmer, PhD
University of Michigan
Plasma Exchange in Sepsis
- L. Keith Scott, MD, MSc, FCCM
LSU Health
Debate: Role of Pheresis in TMA
- Saad Ghafoor, MD
St. Jude Children’s Research Hospital - Nabil Tabish, MD, MS
St. Jude Children’s Research Hospital
Debate: Role of Specialized ICU v. General PICU
- R. Ray Morrison, MD
St. Jude Children’s Research Hospital - Joe Brierly, MD
Great Ormond Street Hospital for Children-London
Role of AI in Pediatric Critical Care
- Ahmed Said, MD, PhD
Washington University in St. Louis
Panel Discussion: How to Use AI in Pediatric Onco-Critical Care
- Hyun Jung (HJ) Park, PhD
University of Pittsburgh - Ahmed Said, MD, PhD
Washington University in St. Louis - Melissa Hines, MD
St. Jude Children’s Research Hospital - Jennifer McArthur, DO
St. Jude Children’s Research Hospital
Chronic Pulmonary Complications After HCT
- Gregory Yanik, MD
University of Michigan
Lung Transplant in Pediatric Onco-Critical Care
- Shailendra Das, DO
Texas Children's
Advances in Interventional Radiology in Pediatric Onco-Critical Care
- Michael Temple, MD
St. Jude Children’s Research Hospital
Role of 3D and VR in the Patient Family Experience and Palliative Care in Pediatric Oncology and Critical Care
- Zach Abramson, DMD, MD
St. Jude Children’s Research Hospital
Role of Immunizations in Pediatric Oncology
- Richard Webby, PhD
St. Jude Children’s Research Hospital
Advances in Therapy for Infants with Brain Tumors
- Aditi Bagchi, MD, PhD
St. Jude Children’s Research Hospital
Panel Discussion: Interdisciplinary Approach to Clinical Research on Genetic Differences in Pediatric Onco-Critical Care
- Heidi Flori, MD, FAAP
University of Michigan - Mary K. Dahmer, PhD
University of Michigan - St. Jude Children’s Research Hospital Bioethics Program
Global Difficult Cases: Nursing Sessions Machine AI Learning in Nursing
- Ahmed Said, MD, PhD
Washington University in St. Louis
Veno-occlusive Disease
- Kathleen Maloney, PNP
Medical College of Wisconsin
Serial Neurological Assessment in Pediatrics
- Katie A. Smith, DNP, MHP, ACCNS-P, CPN, CHES
Children’s Hospital of Philadelphia
Difficult Cases
- Laurie Shoulders, ICU RN
St. Jude Children’s Research Hospital - Nieske van Beek
Princess Maxima Center for Pediatric Oncology
- Heidi Flori, MD, FAAP
-
Abstracts must be submitted by 11:59 p.m. CST, on January 26, 2026. Abstract submissions will be evaluated anonymously and scored by the appropriate IPOCCS Abstract Committee. Full information about the abstract submission and selection process are included on the submission website.
-
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Jude Children’s Research Hospital, Princess Máxima Center for pediatric Oncology, and Great Ormond Street Hospital for Children. St. Jude Children’s Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been submitted to the American Association of Critical-Care Nurses for approval to award contact hours. The American Association of Critical-Care Nurses is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Disclosure of Financial Relationships
All individuals in a position to control the content of this CE activity (such as faculty, presenters, and planners) were asked to complete a statement regarding all financial relationships between themselves and any ineligible company (defined by the ACCME as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients).
All relevant relationships will be disclosed below.